Categories
All
Biotech
Clinical Trials
Health Tech
News
Pharma
Regulatory
The Physician Gap That’s Slowing Life Sciences
Bridging the Gap Between Microbiome Research and Patient Care
Protecting R&D and Clinical Trial Data in the Age of AI
Medical Writers Become Strategic Partners
HIV Treatment Revolution: Infected Cells Now Trigger Their Own Elimination
Microplastics From Food Packaging Linked to Liver Damage, New Study Finds
Weekly News Roundup | 16 March 2026
Imperial, Oxford & GSK launch £11M Digital Twin Organ Centre
Reflections and Healing at the End of Life
Why Fertility Diagnostics Must Move to Continuous Remote Monitoring
The Microbiome: The Missing Layer in Modern Metabolic Care
Redefining Fertility & Modern Motherhood with Dr. Roohi Jeelani and Hayley
Breaking Silos: How AI Agents are Standardizing Drug Discovery
From Hype to Hard Science: Unlocking MSC Therapy’s Promise
Beyond Hallucinated Binders: The Enzymatic Frontier for Generative AI
Antibiotic Resistance: The Silent Pandemic Undermining Modern Medicine
Why Hypoxia Workstations are Becoming Standard Lab Infrastructure
Natural Product Drug Discovery Returns With New Anti Cancer Insights
Biotech’s Funding Winter is Over, but M&A Will Remain Selective
A Career in Life Sciences: Pathways, Possibilities and Support
Obesity Redefinition Studies Challenge Longstanding Clinical Standards
Japan’s iPSC Breakthrough: A New Hope for Spinal Cord Injury Repair
Basecamp Research Debuts World’s First AI for Programmable Gene Insertion
Peptide and Biomolecule Research Bridges Consumer and Clinical Innovation
Functional Gut Clinic Launches GI Clinical Trials Division
Pharvaris Announces Positive Phase 3 Results for Deucrictibant
Otsuka Wins Approval for Novel Rare Kidney Drug
New Hope for Patients with Hereditary Hemorrhagic Telangiectasia
ALS- Clinical Signals of a “Synaptic Regenerative” Approach!
Ground-Breaking Gene Therapy for Hunter Syndrome
The Future of Clinical Trials: Virtual, Decentralised, and Patient-Led
US Scientists Create Human Embryos from Skin Cells
Stem Cell Breakthrough: Woman Reverses Type 1 Diabetes Using Her Own Cells
The Dawn of a New Era: World’s First mRNA Lung Cancer Vaccine Enters Global Clinical Trials
Pregnancy, the Brain, and the Nervous System
Australian Healthcare Reviews Mean Nothing Without the Right Governance
GMCA: Why Unlocking Longevity Research Will Drive Innovation
NIH Scientists Pioneer “Digital Twin” of Eye Cells
Doctors Warn AI Diet Advice Should Not Replace Medical Care
Fertility Decisions and AI: Clarity Without False Certainty
AI-Enabled Pathology: De-risking Oncology Drug Development
Why Sugar May Matter More Than We Thought
Cera and Promptly Health Partner to Bridge the ‘Evidence Gap’
RCM Efficiency: Solving Insurance Denials & Margin Pressure
Chronic Pain and Neuroplastic Pain: Rethinking How Pain is Created
Neuroscience of Trauma, Stress & Alcohol: Integrated Treatment
Professor Chris Van Tulleken to Headline Smart Ageing Summit in May
UK Expertise: Faster Cancer Diagnosis and Cleaner Energy
Prices for GLP-1 Drugs Are Falling Fast and Forcing Companies to Adapt
AuDHD: Rethinking the Overlap Between Autism and ADHD
Uniphar | Clinical merges with BMclinical
Thousands Recruited for “New Era” Severe Mental Illness Study
THX Pharma and Biocodex Sign Licensing Deal for Batten-1 and TX01 Therapies
Auxilium and MBI Launch Life Sciences Accelerator Cohort in Worcester
Statins Safer Than Previously Thought, Major Review Finds
Lilly Finalizes “Lilly Lehigh Valley” with $3.5B Manufacturing Hub
AstraZeneca Commits $15bn to Expand R&D and Manufacturing in China
Phacilitate Unites CGT Community for New Era Defined by Collaboration
Metformin and Type 2 Diabetes: Benefits, Limitations and the Role of Diet
Part III – China’s Biopharma Scale: Deals, Reimbursement and GLP-1s
J&J Axes Eczema Drug From $1.25B Acquisition
How the UK May Be Undervaluing Life Sciences Manufacturing Investments
Part II – Trade, Capital and the UK Life Sciences Strategy
Manufacturing and Supply Chain Resilience for Advanced Therapies
Part I – Platforms, Pipelines and Incentives in Global Biopharma
Are Mega-Deals Back for Real?
Pharma 5.0: The Future of Human-Centric, Intelligent, Sustainable Medicine
Autolus CAR-T Offers Hope to Adults with Aggressive Blood Cancer
Decision Frameworks in Pharma
Follow the Science? It Would Rather Follow a Leader… (2025 Update)
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.